AU4544600A - Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof - Google Patents
Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereofInfo
- Publication number
- AU4544600A AU4544600A AU45446/00A AU4544600A AU4544600A AU 4544600 A AU4544600 A AU 4544600A AU 45446/00 A AU45446/00 A AU 45446/00A AU 4544600 A AU4544600 A AU 4544600A AU 4544600 A AU4544600 A AU 4544600A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- blood cells
- circulating blood
- preferably monocytes
- monocytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000000601 blood cell Anatomy 0.000 title 1
- 210000001616 monocyte Anatomy 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4614—Monocytes; Macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99106800 | 1999-04-06 | ||
EP99106800 | 1999-04-06 | ||
PCT/EP2000/003087 WO2000060054A1 (en) | 1999-04-06 | 2000-04-06 | Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4544600A true AU4544600A (en) | 2000-10-23 |
Family
ID=8237911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45446/00A Abandoned AU4544600A (en) | 1999-04-06 | 2000-04-06 | Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1165754A1 (en) |
AU (1) | AU4544600A (en) |
WO (1) | WO2000060054A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69821011T3 (en) | 1997-10-02 | 2009-01-08 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method of modulating the neovascularization and / or growth of collateral arteries and / or other arteries from existing arteriolar compounds |
AU2001261737A1 (en) * | 2000-05-18 | 2001-11-26 | Genetix Pharmaceuticals, Inc. | Methods and compositions for promoting angiogenesis using monocytes |
CN1512894B (en) * | 2001-03-30 | 2010-06-16 | 格林维尔医院***公司 | Monocyte specific particulate delivery carrier |
US20040191215A1 (en) * | 2003-03-25 | 2004-09-30 | Michael Froix | Compositions for induction of a therapeutic response |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2709309B1 (en) * | 1993-08-25 | 1995-11-10 | Centre Nat Rech Scient | Cellular compositions, preparation and therapeutic uses. |
EP0969877B1 (en) * | 1997-04-04 | 2003-02-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
US20020068048A1 (en) * | 1997-09-05 | 2002-06-06 | Patrick A. Dreyfus | Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
DE69821011T3 (en) * | 1997-10-02 | 2009-01-08 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method of modulating the neovascularization and / or growth of collateral arteries and / or other arteries from existing arteriolar compounds |
-
2000
- 2000-04-06 AU AU45446/00A patent/AU4544600A/en not_active Abandoned
- 2000-04-06 WO PCT/EP2000/003087 patent/WO2000060054A1/en not_active Application Discontinuation
- 2000-04-06 EP EP00926832A patent/EP1165754A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1165754A1 (en) | 2002-01-02 |
WO2000060054A1 (en) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0102766A3 (en) | Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them | |
HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
IL148876A0 (en) | Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
HUP0203403A3 (en) | New imidazole derivatives, pharmaceutical compositions containing them and their use | |
AU3956900A (en) | Substituted imidazoles, their preparation and use | |
EP1072266B8 (en) | Thienylazolylalcoxyethanamines, their preparation and their application as medicaments | |
IL150346A0 (en) | Benzazole derivatives, their preparation and pharmaceutical compositions containing them | |
HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
HUP0203821A3 (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same | |
HUP0203645A3 (en) | Phenylpiperazinyl derivatives, pharmaceutical compositions containing them and their use | |
ZA200109602B (en) | Purine derivatives, preparation method and pharmaceutical compositions containing same. | |
AU7748200A (en) | Hypoxia-related human genes, proteins, and uses thereof | |
HUP0201692A2 (en) | Streptogramin derivatives, preparation and compositions containing them | |
HUP0201910A3 (en) | Novel aminobenzophenones, pharmaceutical compositions containing them and their use | |
ZA200203294B (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them. | |
AU1730201A (en) | Proteoglycans and pharmaceutical compositions comprising them | |
HUP0104834A3 (en) | Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation | |
HUP0200242A3 (en) | Pyrazole-3-on-derivatives as factor xa inhibitors, pharmaceutical compositions containing them, their preparation and their use | |
AU4544600A (en) | Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof | |
HUP0201810A3 (en) | Sootepenseone and its derivatives, their preparation and use as medicament | |
HUP0300330A3 (en) | Oligosaccharides, pharmaceutical compositions containing them and preparation thereof | |
AU4884701A (en) | Malonanilic acid derivatives, medicinal compositions containing the same and usethereof | |
AU4543500A (en) | Pharmaceutical compositions and uses | |
HK1047037A1 (en) | Pharmaceutical preparations containing nanosols ofchitosan, and their preparation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |